Hormones and antiepileptic drugs
E. Taubøll,
E. Taubøll
Department of Neurology, Rikshospitalet, University of Oslo, Norway
Search for more papers by this authorE. Taubøll,
E. Taubøll
Department of Neurology, Rikshospitalet, University of Oslo, Norway
Search for more papers by this authorFirst published: 02 January 2002
References
- 1 Coulam CB & Annegers JF. Do anticonvulsants reduce the efficacy of oral contraceptives? Epilepsia 1979; 20: 519–525.
- 2 Herzog AG. Disorders of reproduction and fertility. In: J Engel, TA Pedley, eds. Epilepsy: A comprehensive textbook. Philadelphia: Lippincott-Raven Publishers, 1997: 2013–2019.
- 3 Oppenheimer JH, Fischer LV, Nielson KM & Jailer JW. Depression of the serum protein-bound iodine level by diphenylhydantoin. J Clin Endocrinol Metab 1961; 21: 252–262.
- 4 Strandjord RE & Johannessen SI. Single-drug therapy with carbamazepine in patients with epilepsy: serum levels and clinical effect. Epilepsia 1980; 21: 655–662.
- 5 Strandjord RE, Aanderud S, Myking OL & Johannessen SI. Influence of carbamazepine on serum thyroxine and triiodothyronine in patients with epilepsy. Acta Neurol Scand 1981; 63: 111–121.
- 6 Isojärvi JIT, Pakarinen AJ & Myllylä VV. Thyroid function with antiepileptic drugs. Epilepsia 1992; 33: 142–148.
- 7 Margraf JW & Dreifuss FE. Amenorrhea following initiation of therapy with valproic acid. Neurology 1981; 31: 159.
- 8 Isojärvi JIT, Laatikainen TJ, Pakarinen AJ, Juntunen KTS & Myllylä VV. Polycystic ovaries and hyperandrogenism in women taking valproate for epilepsy. New Engl J Med 1993; 329: 1383–1388.
- 9 Isojärvi JIT, Laatikainen TJ, Knip M, Pakarinen AJ, Juntunen KTS & Myllylä VV. Obesity and endocrine disorders in women taking valproate for epilepsy. Ann Neurol 1996; 39: 579–584.
- 10 Isojärvi JIT, Taubøll E & Pakarinen AJ et al. Valproate related endocrine risks in women with epilepsy – a multicenter study. Epilepsia 1998; 39 (suppl 6): 220–221.
- 11 Taubøll E, Isojärvi JIT, Flinstad Harbo H, Pakarinen AJ & Gjerstad L. Long-term valproate treatment induces changes in ovarian morphology and serum sex steroid hormone levels in female Wistar rats. Seizure 1999; 8: 490–493.
- 12 RØste LS, Taubøll E, Berner Aa, Isojärvi JIT & Gjerstad L. Valproate, but not lamotrigine, induces ovarian morphological changes in Wistar rats. Exp Toxicol Pathol 2000, in press.
- 13 Yerby MS & McCoy GB. Male infertility: possible association with valproate exposure. Epilepsia 1999; 40; 520–521.
- 14 Walker RM, Smith GS, Barsoum NJ & Macallum GE. Preclinical toxicology of the anticonvulsant calcium valproate. Toxicology 1990; 63: 137–155.
- 15 Abbott laboratories, patient information leaflet, 1997, Ref: 03–4757-R4.
- 16 Snyder PJ & Badura LL. Chronic administration of sodium valproic acid slows pubertal maturation in inbred DBA/2J mice: Skeletal, histological, and endocrinological evidence. Epilepsy Res 1995; 20: 203–211.
- 17 Kühn-Velten WN, Herzog AG & Müller MR. Acute effects of anticonvulsant drugs on gonadotropin-stimulated and precursor-supported androgen production in the rat testis. Eur J Pharmacol 1990; 181: 151–155.
